|
1
|
Goetz R and Mohammadi M: Exploring
mechanisms of FGF signalling through the lens of structural
biology. Nat Rev Mol Cell Biol. 14:166–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ornitz DM and Itoh N: The fibroblast
growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol.
4:215–266. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trueb B: Biology of FGFRL1, the fifth
fibroblast growth factor receptor. Cell Mol Life Sci. 68:951–964.
2011. View Article : Google Scholar
|
|
4
|
Wiedemann M and Trueb B: Characterization
of a novel protein (FGFRL1) from human cartilage related to FGF
receptors. Genomics. 69:275–279. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sleeman M, Fraser J, McDonald M, Yuan S,
White D, Grandison P, Kumble K, Watson JD and Murison JG:
Identification of a new fibroblast growth factor receptor, FGFR5.
Gene. 271:171–182. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rieckmann T, Zhuang L, Flück CE and Trueb
B: Characterization of the first FGFRL1 mutation identified in a
craniosynostosis patient. Biochim Biophys Acta. 1792:112–121. 2009.
View Article : Google Scholar
|
|
7
|
Silva PN, Altamentova SM, Kilkenny DM and
Rocheleau JV: Fibroblast growth factor receptor like-1 (FGFRL1)
interacts with SHP-1 phosphatase at insulin secretory granules and
induces beta-cell ERK1/2 protein activation. J Biol Chem.
288:17859–17870. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baertschi S, Zhuang L and Trueb B: Mice
with a targeted disruption of the Fgfrl1 gene die at birth due to
alterations in the diaphragm. FEBS J. 274:6241–6253. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Catela C, Bilbao-Cortes D, Slonimsky E,
Kratsios P, Rosenthal N and Te Welscher P: Multiple congenital
malformations of Wolf-Hirschhorn syndrome are recapitulated in
Fgfrl1 null mice. Dis Model Mech. 2:283–294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gerber SD, Steinberg F, Beyeler M,
Villiger PM and Trueb B: The murine Fgfrl1 receptor is essential
for the development of the metanephric kidney. Dev Biol.
335:106–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amann R, Wyder S, Slavotinek AM and Trueb
B: The FgfrL1 receptor is required for development of slow muscle
fibers. Dev Biol. 394:228–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gerber SD, Amann R, Wyder S and Trueb B:
Comparison of the gene expression profiles from normal and Fgfrl1
deficient mouse kidneys reveals downstream targets of Fgfrl1
signaling. PLoS One. 7:e334572012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bluteau G, Zhuang L, Amann R and Trueb B:
Targeted disruption of the intracellular domain of receptor FgfrL1
in mice. PLoS One. 9:e1052102014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shibata H and Yagi T: Rate assay of
N-acetyl-beta-D-hexosaminidase with 4-nitrophenyl
N-acetyl-beta-D-glucosaminide as an artificial substrate. Clin Chim
Acta. 251:53–64. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu H, Duchesne L, Rudland PS and Fernig
DG: The heparan sulfate co-receptor and the concentration of
fibroblast growth factor-2 independently elicit different
signalling patterns from the fibroblast growth factor receptor.
Cell Commun Signal. 8:142010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsuchiya S, Fujiwara T, Sato F, Shimada Y,
Tanaka E, Sakai Y, Shimizu K and Tsujimoto G: MicroRNA-210
regulates cancer cell proliferation through targeting fibroblast
growth factor receptor-like 1 (FGFRL1). J Biol Chem. 286:420–428.
2011. View Article : Google Scholar :
|
|
17
|
Shimada Y, Okumura T, Nagata T, Hashimoto
I, Sawada S, Yoshida T, Fukuoka J, Shimizu K and Tsukada K:
Expression analysis of fibroblast growth factor receptor-like 1
(FGFRL1) in esophageal squamous cell carcinoma. Esophagus.
11:48–53. 2014. View Article : Google Scholar
|
|
18
|
Rieckmann T, Kotevic I and Trueb B: The
cell surface receptor FGFRL1 forms constitutive dimers that promote
cell adhesion. Exp Cell Res. 314:1071–1081. 2008. View Article : Google Scholar
|
|
19
|
Trueb B, Zhuang L, Taeschler S and
Wiedemann M: Characterization of FGFRL1, a novel fibroblast growth
factor (FGF) receptor preferentially expressed in skeletal tissues.
J Biol Chem. 278:33857–33865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Steinberg F, Gerber SD, Rieckmann T and
Trueb B: Rapid fusion and syncytium formation of heterologous cells
upon expression of the FGFRL1 receptor. J Biol Chem.
285:37704–37715. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuang L, Pandey AV, Villiger PM and Trueb
B: Cell-cell fusion induced by the Ig3 domain of receptor FGFRL1 in
CHO cells. Biochim Biophys Acta. 1853(10 Pt A): 2273–2285. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mandai K, Rikitake Y, Mori M and Takai Y:
Nectins and nectin-like molecules in development and disease. Curr
Top Dev Biol. 112:197–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Samanta D and Almo SC: Nectin family of
cell-adhesion molecules: structural and molecular aspects of
function and specificity. Cell Mol Life Sci. 72:645–658. 2015.
View Article : Google Scholar
|
